BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7319186)

  • 1. [Limitations of long-term treatment with vasodilator agents in increasing maximum functional capacity in patients with left ventricular insufficiency].
    Gronda E; Mafrici A; Ferrari D; Cataldo G; Salvadè P; Pirelli S; Mauri F; Faletra F; Carù B
    G Ital Cardiol; 1981; 11(6):803-11. PubMed ID: 7319186
    [No Abstract]   [Full Text] [Related]  

  • 2. [Systolic intervals in dilated heart insufficiency. Influence of vasodilator treatment].
    González-Juanatey JR; Amaro Cendón A; Vega Fernández M; Gil de la Peña M
    Med Clin (Barc); 1988 Jan; 90(3):93-6. PubMed ID: 3280894
    [No Abstract]   [Full Text] [Related]  

  • 3. Current indications for vasodilator therapy for left ventricular failure.
    Franciosa JA
    Compr Ther; 1985 Mar; 11(3):39-46. PubMed ID: 2983926
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of cardiac insufficiency with systemic vasodilator agents].
    García Puig J; Gil Aguado A; Arnalich F; Gaspar G; Anciones B; Vázquez JJ
    Med Clin (Barc); 1980 Nov; 75(9):398-403. PubMed ID: 7464335
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of vasodilator therapy in the management of the patient with acute myocardial infarction.
    Wagner GC; Robinson PH
    Prim Care; 1981 Sep; 8(3):467-81. PubMed ID: 6796986
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute hemodynamic responses to vasodilator therapy in congestive heart failure.
    Ribner HS; Bresnahan D; Hsieh AM; Silverman R; Tommaso C; Coath A; Askenazi J
    Prog Cardiovasc Dis; 1982; 25(1):1-42. PubMed ID: 6287524
    [No Abstract]   [Full Text] [Related]  

  • 7. Principles of treatment of left ventricular failure.
    Taylor SH; Silke B; Nelson GI
    Eur Heart J; 1982 Dec; 3 Suppl D():19-43. PubMed ID: 6761126
    [No Abstract]   [Full Text] [Related]  

  • 8. [Vasodilator agents in the therapeutic arsenal of cardiac insufficiency].
    Lavitola Pde L; Higa SS
    Rev Paul Med; 1986; 104(3):136-40. PubMed ID: 3563266
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vasodilator therapy in management of chronic heart failure (author's transl)].
    Letac B; Champoud O; Moore N
    Therapie; 1981; 36(1):1-10. PubMed ID: 7015550
    [No Abstract]   [Full Text] [Related]  

  • 10. [Peripheral vasodilator agents in cardiology].
    Khomenko VL; Pomerantsev VP; Vasiuk IuA
    Sov Med; 1980; (12):70-5. PubMed ID: 6784251
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemodynamic and metabolic effects of vasodilators, nitrates, hydralazine, prazosin and captopril in chronic ischemic heart failure.
    Chatterjee K; Rouleau JL
    Acta Med Scand Suppl; 1981; 651():295-303. PubMed ID: 7034478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Modern vasodilator medication in refractory cardiac insufficiency].
    Stanciu L; Branea I; Riviş I; Radivoievici A; Mancaş S; Păunescu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(2):129-34. PubMed ID: 6139858
    [No Abstract]   [Full Text] [Related]  

  • 13. [Vasodilator agents in the treatment of cardiac insufficiency].
    Bertel O
    Ther Umsch; 1984 Feb; 41(2):117-24. PubMed ID: 6424258
    [No Abstract]   [Full Text] [Related]  

  • 14. Captopril in congestive heart failure: improved left ventricular function with decreased metabolic cost.
    Chatterjee K; Rouleau JL; Parmley WW
    Am Heart J; 1982 Nov; 104(5 Pt 2):1137-46. PubMed ID: 6291359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasodilator therapy for chronic heart failure.
    Chatterjee K; Parmley WW
    Annu Rev Pharmacol Toxicol; 1980; 20():475-512. PubMed ID: 6770743
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacodynamic basis of the use of vasodilators in the treatment of heart failure.
    Taylor SH
    Med J Aust; 1980 Jul; 2(SP1):19-35. PubMed ID: 6775178
    [No Abstract]   [Full Text] [Related]  

  • 17. Vasodilator therapy for chronic congestive heart failure.
    Abrams J
    JAMA; 1985 Dec; 254(21):3070-4. PubMed ID: 3932697
    [No Abstract]   [Full Text] [Related]  

  • 18. Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study.
    Rouleau JL; Chatterjee K; Benge W; Parmley WW; Hiramatsu B
    Circulation; 1982 Apr; 65(4):671-8. PubMed ID: 7037220
    [No Abstract]   [Full Text] [Related]  

  • 19. [Long-term treatment of cardiac insufficiency with prazosin].
    Grolleau R; Errera J; Gallay P
    Ann Cardiol Angeiol (Paris); 1984; 33(4):247-51. PubMed ID: 6465817
    [No Abstract]   [Full Text] [Related]  

  • 20. Amrinone: a promising new cardiotonic agent in the treatment of chronic cardiac failure.
    Likoff MJ; Weber KT; Andrews V; Janicki JS
    Herz; 1983 Aug; 8(4):199-205. PubMed ID: 6413341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.